+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cosmetic Grade Nicotinamide Mononucleotide Market - Global Forecast 2026-2032- Product Image
Cosmetic Grade Nicotinamide Mononucleotide Market - Global Forecast 2026-2032- Product Image
Sale

Cosmetic Grade Nicotinamide Mononucleotide Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6081618
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cosmetic Grade Nicotinamide Mononucleotide Market is projected to reach USD 705.84 Million in 2026. It is expected to continue growing at a CAGR of 8.05%, reaching USD 1.12 Billion by 2032.

Cosmetic-Grade NMN: Executive Summary and Market Context

Cosmetic-grade nicotinamide mononucleotide (NMN) is an ingredient associated with research into cellular energy metabolism and NAD+ biology. In cosmetics, its relevance is shaped by formulation feasibility, ingredient quality, skin-compatibility evidence, regulatory classification, and consumer interest in science-led aging and wellness concepts. The category remains evidence-sensitive: topical performance, stability, delivery, and product safety must be assessed independently from findings in oral or laboratory research.

Scientific Validation and Formulation Discipline Are Reshaping the Category

The landscape is shifting from novelty-led positioning toward substantiated cosmetic claims and reproducible formulation performance. Product developers are emphasizing raw-material identity, purity testing, contaminant controls, batch consistency, preservation compatibility, packaging protection, and stability across expected storage conditions. Claims increasingly require careful wording so that cosmetic benefits-such as supporting the appearance of vitality, radiance, or skin smoothness-are not presented as drug-like outcomes without appropriate evidence.

Artificial Intelligence Accelerates Discovery, Quality Control, and Consumer Personalization

Artificial intelligence can support ingredient screening, formulation optimization, image-based skin analysis, literature review, demand sensing, and quality-document management. Its value is greatest when models are trained on validated analytical, stability, and consumer data rather than unsupported claims. Industry leaders should maintain human oversight, document data provenance, test model bias, and distinguish algorithmic associations from clinical evidence. AI-generated marketing language also requires regulatory and scientific review before publication.

Regional Insights: Regulation, Science, and Consumer Expectations Vary

North America combines strong interest in evidence-led beauty with close scrutiny of cosmetic claims, ingredient safety, and advertising substantiation. Europe places particular weight on formal cosmetic compliance, safety assessment, responsible claims, and sustainability. Asia-Pacific is influenced by advanced beauty-manufacturing capabilities, active cosmeceutical innovation, and diverse national regulatory systems. Latin America offers varied consumer preferences and regulatory environments, with local registration and labeling requirements important for market access. The Middle East is shaped by premium skincare demand, climate-related formulation considerations, and import-compliance needs. Africa presents diverse consumer and distribution conditions, making affordability, product robustness, local suitability, and regulatory coordination central considerations.

Group Insights: Trade Links and Regulatory Alignment Shape Commercial Execution

ASEAN requires attention to regional cosmetic harmonization alongside country-level implementation and product-notification practices. BRICS markets span substantially different scientific, regulatory, manufacturing, and consumer contexts, so a single commercialization model is unlikely to fit all members. The European Union emphasizes harmonized cosmetic safety, documentation, and claims discipline. G7 markets generally combine sophisticated consumers with high expectations for transparency, substantiation, and quality assurance. GCC markets place importance on import documentation, labeling, premium positioning, and suitability for hot climates. NATO members do not constitute a single cosmetics regime, but their connected supply chains and high compliance expectations make traceability and dependable procurement strategically relevant.

Country Insights: Local Compliance and Consumer Fit Remain Decisive

Australia emphasizes ingredient safety, truthful claims, and clear distinctions between cosmetics and therapeutic products. Brazil and Mexico require careful attention to local registration, labeling, and distribution requirements. Canada and the United States demand robust safety documentation and disciplined claims review, with classification depending on product presentation and intended use. China and South Korea combine sophisticated beauty consumers with demanding quality, documentation, and product-compliance expectations. India is developing advanced beauty and personal-care capabilities while requiring careful assessment of applicable standards and labeling. Japan values quality, stability, and refined product performance. France, Germany, Italy, and Spain operate within the European compliance framework, with strong consumer interest in efficacy and sustainability. The United Kingdom maintains its own post-EU regulatory processes and expects reliable safety and claims documentation. Russia presents additional trade, logistics, and compliance complexities. Across all countries, local legal review should precede launch.

Action Priorities: Build Evidence, Resilient Supply, and Responsible Claims

Leaders should establish a documented evidence program covering identity, purity, impurities, microbiological quality, stability, skin tolerance, and product-specific performance. Formulation teams should test NMN in realistic systems and packaging, while procurement teams qualify multiple compliant sources and verify change-control procedures. Regulatory teams should map each product’s classification, claims, notification or registration pathway, and labeling obligations before commercialization. Commercial teams should use transparent education, avoid implying established medical effects, and tailor communication to local consumer expectations. Finally, organizations should apply AI selectively, with governance controls for data quality, validation, privacy, and human approval.

Research Methodology: Evidence-Based Interpretation of a Specialized Ingredient

This executive summary uses the supplied market scope-cosmetic-grade nicotinamide mononucleotide-and organizes implications across technology, regulation, geography, industry groups, and priority countries. The analysis is qualitative and grounded in established considerations for cosmetic ingredient development: scientific substantiation, formulation science, quality systems, product safety, claims governance, supply-chain resilience, and regional compliance. It does not provide market estimates, forecasts, market shares, or company-specific comparisons. Country and regional observations are directional and should be validated against current legislation, official guidance, and product-specific legal advice before use in commercial decisions.

Conclusion: Credibility and Execution Will Define Cosmetic-Grade NMN Adoption

Cosmetic-grade NMN sits at the intersection of cellular-aging research, premium skincare innovation, and strict expectations for safety and substantiation. Sustainable progress will depend less on broad anti-aging narratives than on verified ingredient quality, stable formulations, appropriate cosmetic claims, transparent evidence, and reliable regulatory execution. Organizations that align scientific rigor with localized compliance, resilient sourcing, and responsible consumer communication will be best positioned to develop credible products as understanding of NMN’s topical role continues to evolve.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Cosmetic Grade Nicotinamide Mononucleotide Market, by Form
7.1. Introduction
7.2. Capsule
7.3. Liquid
7.4. Powder
7.5. Tablet
8. Cosmetic Grade Nicotinamide Mononucleotide Market, by Purity
8.1. Introduction
8.2. 95% to 99%
8.3. 99% and Above
8.4. Below 95%
9. Cosmetic Grade Nicotinamide Mononucleotide Market, by Application
9.1. Introduction
9.2. Anti-Aging
9.2.1. Cream
9.2.1.1. Day Cream
9.2.1.2. Night Cream
9.2.2. Mask
9.2.2.1. Peel-Off Mask
9.2.2.2. Sheet Mask
9.2.3. Serum
9.2.3.1. Eye Serum
9.2.3.2. Facial Serum
9.3. Moisturizing
9.4. Repair
9.5. Skin Whitening
10. Cosmetic Grade Nicotinamide Mononucleotide Market, by Distribution Channel
10.1. Introduction
10.2. Beauty Center
10.3. Dermatology Clinic
10.4. Online Retail
10.4.1. Brand Website
10.4.2. E-Commerce Platform
10.5. Pharmacy
11. Cosmetic Grade Nicotinamide Mononucleotide Market, by End User
11.1. Introduction
11.2. Personal
11.2.1. Adult Consumer
11.2.2. Senior Consumer
11.3. Professional
11.3.1. Aesthetician
11.3.2. Dermatologist
12. Cosmetic Grade Nicotinamide Mononucleotide Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Cosmetic Grade Nicotinamide Mononucleotide Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Cosmetic Grade Nicotinamide Mononucleotide Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Biosynth AG
16.2. ChromaDex, Inc.
16.3. DSM Nutritional Products AG
16.4. Evonik Industries AG
16.5. Hangzhou Yuanye Bio-Technology Co., Ltd.
16.6. Lonza Group Ltd
16.7. Merck KGaA
16.8. Mibelle Biochemistry AG
16.9. Nantong Xiangyuan Biological Technology Co., Ltd.
16.10. Sichuan Kelun Pharmaceutical Co., Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Cosmetic Grade Nicotinamide Mononucleotide Market, Years Considered for the Study
FIGURE 2. Global Cosmetic Grade Nicotinamide Mononucleotide Market, Research Design
FIGURE 3. Global Cosmetic Grade Nicotinamide Mononucleotide Market, Research Framework
FIGURE 4. Global Cosmetic Grade Nicotinamide Mononucleotide Market, Data Triangulation
FIGURE 5. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Form, 2025 vs 2032 (%)
FIGURE 7. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Purity, 2025 vs 2032 (%)
FIGURE 9. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Purity, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Cosmetic Grade Nicotinamide Mononucleotide Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Cosmetic Grade Nicotinamide Mononucleotide Market Segmentation & Coverage
TABLE 2. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, 2017-2032 (USD Million)
TABLE 3. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Form, 2017-2032 (USD Million)
TABLE 4. Global Capsule Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Capsule Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Capsule Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Tablet Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Tablet Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Tablet Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Purity, 2017-2032 (USD Million)
TABLE 17. Global 95% to 99% Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global 95% to 99% Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global 95% to 99% Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global 99% and Above Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global 99% and Above Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global 99% and Above Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Below 95% Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Below 95% Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Below 95% Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Application, 2017-2032 (USD Million)
TABLE 27. Global Anti-Aging Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Anti-Aging Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Anti-Aging Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Cream Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Cream Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Cream Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Day Cream Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Day Cream Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Day Cream Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Night Cream Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Night Cream Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Night Cream Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Mask Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Mask Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Mask Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Peel-Off Mask Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Peel-Off Mask Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Peel-Off Mask Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Sheet Mask Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Sheet Mask Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Sheet Mask Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Eye Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Eye Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Eye Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Facial Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Facial Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Facial Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Moisturizing Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Moisturizing Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Moisturizing Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Repair Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Repair Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Repair Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Skin Whitening Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Skin Whitening Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Skin Whitening Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 67. Global Beauty Center Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Beauty Center Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Beauty Center Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Dermatology Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Dermatology Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Dermatology Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Online Retail Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Online Retail Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Online Retail Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Brand Website Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Brand Website Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Brand Website Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global E-Commerce Platform Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global E-Commerce Platform Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global E-Commerce Platform Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, by End User, 2017-2032 (USD Million)
TABLE 86. Global Personal Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Personal Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Personal Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Adult Consumer Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Adult Consumer Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Adult Consumer Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Senior Consumer Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Senior Consumer Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Senior Consumer Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Professional Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Professional Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Professional Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Aesthetician Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Aesthetician Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Aesthetician Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Dermatologist Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Dermatologist Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Dermatologist Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Form, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Purity, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Application, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Anti-Aging, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Cream, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Mask, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Serum, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Personal, 2017-2032 (USD Million)
TABLE 117. Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Professional, 2017-2032 (USD Million)
TABLE 118. North America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. North America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Form, 2017-2032 (USD Million)
TABLE 120. North America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Purity, 2017-2032 (USD Million)
TABLE 121. North America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. North America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Anti-Aging, 2017-2032 (USD Million)
TABLE 123. North America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Cream, 2017-2032 (USD Million)
TABLE 124. North America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Mask, 2017-2032 (USD Million)
TABLE 125. North America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Serum, 2017-2032 (USD Million)
TABLE 126. North America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 127. North America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 128. North America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. North America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Personal, 2017-2032 (USD Million)
TABLE 130. North America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Professional, 2017-2032 (USD Million)
TABLE 131. Latin America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Latin America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Form, 2017-2032 (USD Million)
TABLE 133. Latin America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Purity, 2017-2032 (USD Million)
TABLE 134. Latin America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Application, 2017-2032 (USD Million)
TABLE 135. Latin America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Anti-Aging, 2017-2032 (USD Million)
TABLE 136. Latin America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Cream, 2017-2032 (USD Million)
TABLE 137. Latin America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Mask, 2017-2032 (USD Million)
TABLE 138. Latin America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Serum, 2017-2032 (USD Million)
TABLE 139. Latin America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 140. Latin America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 141. Latin America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. Latin America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Personal, 2017-2032 (USD Million)
TABLE 143. Latin America Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Professional, 2017-2032 (USD Million)
TABLE 144. Europe Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Europe Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Form, 2017-2032 (USD Million)
TABLE 146. Europe Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Purity, 2017-2032 (USD Million)
TABLE 147. Europe Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Application, 2017-2032 (USD Million)
TABLE 148. Europe Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Anti-Aging, 2017-2032 (USD Million)
TABLE 149. Europe Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Cream, 2017-2032 (USD Million)
TABLE 150. Europe Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Mask, 2017-2032 (USD Million)
TABLE 151. Europe Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Serum, 2017-2032 (USD Million)
TABLE 152. Europe Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 153. Europe Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 154. Europe Cosmetic Grade Nicotinamide Mononucleotide Market Size, by End User, 2017-2032 (USD Million)
TABLE 155. Europe Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Personal, 2017-2032 (USD Million)
TABLE 156. Europe Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Professional, 2017-2032 (USD Million)
TABLE 157. Middle East Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Region, 2017-2032 (USD Million)
TABLE 158. Middle East Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Form, 2017-2032 (USD Million)
TABLE 159. Middle East Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Purity, 2017-2032 (USD Million)
TABLE 160. Middle East Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. Middle East Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Anti-Aging, 2017-2032 (USD Million)
TABLE 162. Middle East Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Cream, 2017-2032 (USD Million)
TABLE 163. Middle East Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Mask, 2017-2032 (USD Million)
TABLE 164. Middle East Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Serum, 2017-2032 (USD Million)
TABLE 165. Middle East Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 166. Middle East Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 167. Middle East Cosmetic Grade Nicotinamide Mononucleotide Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. Middle East Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Personal, 2017-2032 (USD Million)
TABLE 169. Middle East Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Professional, 2017-2032 (USD Million)
TABLE 170. Africa Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Region, 2017-2032 (USD Million)
TABLE 171. Africa Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Form, 2017-2032 (USD Million)
TABLE 172. Africa Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Purity, 2017-2032 (USD Million)
TABLE 173. Africa Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. Africa Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Anti-Aging, 2017-2032 (USD Million)
TABLE 175. Africa Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Cream, 2017-2032 (USD Million)
TABLE 176. Africa Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Mask, 2017-2032 (USD Million)
TABLE 177. Africa Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Serum, 2017-2032 (USD Million)
TABLE 178. Africa Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 179. Africa Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 180. Africa Cosmetic Grade Nicotinamide Mononucleotide Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. Africa Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Personal, 2017-2032 (USD Million)
TABLE 182. Africa Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Professional, 2017-2032 (USD Million)
TABLE 183. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Group, 2017-2032 (USD Million)
TABLE 184. ASEAN Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Group, 2017-2032 (USD Million)
TABLE 185. ASEAN Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Form, 2017-2032 (USD Million)
TABLE 186. ASEAN Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Purity, 2017-2032 (USD Million)
TABLE 187. ASEAN Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Application, 2017-2032 (USD Million)
TABLE 188. ASEAN Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Anti-Aging, 2017-2032 (USD Million)
TABLE 189. ASEAN Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Cream, 2017-2032 (USD Million)
TABLE 190. ASEAN Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Mask, 2017-2032 (USD Million)
TABLE 191. ASEAN Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Serum, 2017-2032 (USD Million)
TABLE 192. ASEAN Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 193. ASEAN Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 194. ASEAN Cosmetic Grade Nicotinamide Mononucleotide Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. ASEAN Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Personal, 2017-2032 (USD Million)
TABLE 196. ASEAN Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Professional, 2017-2032 (USD Million)
TABLE 197. GCC Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Group, 2017-2032 (USD Million)
TABLE 198. GCC Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Form, 2017-2032 (USD Million)
TABLE 199. GCC Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Purity, 2017-2032 (USD Million)
TABLE 200. GCC Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Application, 2017-2032 (USD Million)
TABLE 201. GCC Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Anti-Aging, 2017-2032 (USD Million)
TABLE 202. GCC Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Cream, 2017-2032 (USD Million)
TABLE 203. GCC Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Mask, 2017-2032 (USD Million)
TABLE 204. GCC Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Serum, 2017-2032 (USD Million)
TABLE 205. GCC Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 206. GCC Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 207. GCC Cosmetic Grade Nicotinamide Mononucleotide Market Size, by End User, 2017-2032 (USD Million)
TABLE 208. GCC Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Personal, 2017-2032 (USD Million)
TABLE 209. GCC Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Professional, 2017-2032 (USD Million)
TABLE 210. European Union Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Group, 2017-2032 (USD Million)
TABLE 211. European Union Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Form, 2017-2032 (USD Million)
TABLE 212. European Union Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Purity, 2017-2032 (USD Million)
TABLE 213. European Union Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Application, 2017-2032 (USD Million)
TABLE 214. European Union Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Anti-Aging, 2017-2032 (USD Million)
TABLE 215. European Union Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Cream, 2017-2032 (USD Million)
TABLE 216. European Union Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Mask, 2017-2032 (USD Million)
TABLE 217. European Union Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Serum, 2017-2032 (USD Million)
TABLE 218. European Union Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 219. European Union Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 220. European Union Cosmetic Grade Nicotinamide Mononucleotide Market Size, by End User, 2017-2032 (USD Million)
TABLE 221. European Union Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Personal, 2017-2032 (USD Million)
TABLE 222. European Union Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Professional, 2017-2032 (USD Million)
TABLE 223. BRICS Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Group, 2017-2032 (USD Million)
TABLE 224. BRICS Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Form, 2017-2032 (USD Million)
TABLE 225. BRICS Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Purity, 2017-2032 (USD Million)
TABLE 226. BRICS Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. BRICS Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Anti-Aging, 2017-2032 (USD Million)
TABLE 228. BRICS Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Cream, 2017-2032 (USD Million)
TABLE 229. BRICS Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Mask, 2017-2032 (USD Million)
TABLE 230. BRICS Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Serum, 2017-2032 (USD Million)
TABLE 231. BRICS Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 232. BRICS Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 233. BRICS Cosmetic Grade Nicotinamide Mononucleotide Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. BRICS Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Personal, 2017-2032 (USD Million)
TABLE 235. BRICS Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Professional, 2017-2032 (USD Million)
TABLE 236. G7 Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Group, 2017-2032 (USD Million)
TABLE 237. G7 Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Form, 2017-2032 (USD Million)
TABLE 238. G7 Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Purity, 2017-2032 (USD Million)
TABLE 239. G7 Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Application, 2017-2032 (USD Million)
TABLE 240. G7 Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Anti-Aging, 2017-2032 (USD Million)
TABLE 241. G7 Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Cream, 2017-2032 (USD Million)
TABLE 242. G7 Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Mask, 2017-2032 (USD Million)
TABLE 243. G7 Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Serum, 2017-2032 (USD Million)
TABLE 244. G7 Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 245. G7 Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 246. G7 Cosmetic Grade Nicotinamide Mononucleotide Market Size, by End User, 2017-2032 (USD Million)
TABLE 247. G7 Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Personal, 2017-2032 (USD Million)
TABLE 248. G7 Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Professional, 2017-2032 (USD Million)
TABLE 249. NATO Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Group, 2017-2032 (USD Million)
TABLE 250. NATO Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Form, 2017-2032 (USD Million)
TABLE 251. NATO Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Purity, 2017-2032 (USD Million)
TABLE 252. NATO Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Application, 2017-2032 (USD Million)
TABLE 253. NATO Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Anti-Aging, 2017-2032 (USD Million)
TABLE 254. NATO Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Cream, 2017-2032 (USD Million)
TABLE 255. NATO Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Mask, 2017-2032 (USD Million)
TABLE 256. NATO Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Serum, 2017-2032 (USD Million)
TABLE 257. NATO Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 258. NATO Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 259. NATO Cosmetic Grade Nicotinamide Mononucleotide Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. NATO Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Personal, 2017-2032 (USD Million)
TABLE 261. NATO Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Professional, 2017-2032 (USD Million)
TABLE 262. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Country, 2017-2032 (USD Million)
TABLE 263. United States Cosmetic Grade Nicotinamide Mononucleotide Market Size, 2017-2032 (USD Million)
TABLE 264. United States Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Form, 2017-2032 (USD Million)
TABLE 265. United States Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Purity, 2017-2032 (USD Million)
TABLE 266. United States Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Application, 2017-2032 (USD Million)
TABLE 267. United States Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Anti-Aging, 2017-2032 (USD Million)
TABLE 268. United States Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Cream, 2017-2032 (USD Million)
TABLE 269. United States Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Mask, 2017-2032 (USD Million)
TABLE 270. United States Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Serum, 2017-2032 (USD Million)
TABLE 271. United States Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 272. United States Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 273. United States Cosmetic Grade Nicotinamide Mononucleotide Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. United States Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Personal, 2017-2032 (USD Million)
TABLE 275. United States Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Professional, 2017-2032 (USD Million)
TABLE 276. Canada Cosmetic Grade Nicotinamide Mononucleotide Market Size, 2017-2032 (USD Million)
TABLE 277. Canada Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Form, 2017-2032 (USD Million)
TABLE 278. Canada Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Purity, 2017-2032 (USD Million)
TABLE 279. Canada Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Application, 2017-2032 (USD Million)
TABLE 280. Canada Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Anti-Aging, 2017-2032 (USD Million)
TABLE 281. Canada Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Cream, 2017-2032 (USD Million)
TABLE 282. Canada Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Mask, 2017-2032 (USD Million)
TABLE 283. Canada Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Serum, 2017-2032 (USD Million)
TABLE 284. Canada Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 285. Canada Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 286. Canada Cosmetic Grade Nicotinamide Mononucleotide Market Size, by End User, 2017-2032 (USD Million)
TABLE 287. Canada Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Personal, 2017-2032 (USD Million)
TABLE 288. Canada Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Professional, 2017-2032 (USD Million)
TABLE 289. Mexico Cosmetic Grade Nicotinamide Mononucleotide Market Size, 2017-2032 (USD Million)
TABLE 290. Mexico Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Form, 2017-2032 (USD Million)
TABLE 291. Mexico Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Purity, 2017-2032 (USD Million)
TABLE 292. Mexico Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Application, 2017-2032 (USD Million)
TABLE 293. Mexico Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Anti-Aging, 2017-2032 (USD Million)
TABLE 294. Mexico Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Cream, 2017-2032 (USD Million)
TABLE 295. Mexico Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Mask, 2017-2032 (USD Million)
TABLE 296. Mexico Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Serum, 2017-2032 (USD Million)
TABLE 297. Mexico Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 298. Mexico Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 299. Mexico Cosmetic Grade Nicotinamide Mononucleotide Market Size, by End User, 2017-2032 (USD Million)
TABLE 300. Mexico Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Personal, 2017-2032 (USD Million)
TABLE 301. Mexico Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Professional, 2017-2032 (USD Million)
TABLE 302. Brazil Cosmetic Grade Nicotinamide Mononucleotide Market Size, 2017-2032 (USD Million)
TABLE 303. Brazil Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Form, 2017-2032 (USD Million)
TABLE 304. Brazil Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Purity, 2017-2032 (USD Million)
TABLE 305. Brazil Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Application, 2017-2032 (USD Million)
TABLE 306. Brazil Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Anti-Aging, 2017-2032 (USD Million)
TABLE 307. Brazil Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Cream, 2017-2032 (USD Million)
TABLE 308. Brazil Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Mask, 2017-2032 (USD Million)
TABLE 309. Brazil Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Serum, 2017-2032 (USD Million)
TABLE 310. Brazil Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 311. Brazil Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Online Retail, 2017-2032 (USD Million)
TABLE 312. Brazil Cosmetic Grade Nicotinamide Mononucleotide Market Size, by End User, 2017-2032 (USD Million)
TABLE 313. Brazil Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Personal, 2017-2032 (USD Million)
TABLE 314. Brazil Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Professional, 2017-2032 (USD Million)
TABLE 315. United Kingdom Cosmetic Grade Nicotinamide Mononucleotide Market Size, 2017-2032 (USD Million)
TABLE 316. United Kingdom Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Form, 2017-2032 (USD Million)
TABLE 317. United Kingdom Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Purity, 2017-2032 (USD Million)
TABLE 318. United Kingdom Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Application, 2017-2032 (USD Million)
TABLE 319. United Kingdom Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Anti-Aging, 2017-2032 (USD Million)
TABLE 320. United Kingdom Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Cream, 2017-2032 (USD Million)
TABLE 321. United Kingdom Cosmetic Grade Nicotinamide Mononucleotide Market Size, by Mask, 2017-2032 (USD Million)

Companies Mentioned

  • Biosynth AG
  • ChromaDex, Inc.
  • DSM Nutritional Products AG
  • Evonik Industries AG
  • Hangzhou Yuanye Bio-Technology Co., Ltd.
  • Lonza Group Ltd
  • Merck KGaA
  • Mibelle Biochemistry AG
  • Nantong Xiangyuan Biological Technology Co., Ltd.
  • Sichuan Kelun Pharmaceutical Co., Ltd.

Related Topics

Related Reports

Beta-Nicotinamide Mononucleotide Market - Global Forecast 2026-2032 - Product Image

Beta-Nicotinamide Mononucleotide Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
a-Nicotinamide Mononucleotide (CAS 7298-94-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

a-Nicotinamide Mononucleotide (CAS 7298-94-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
ß-Nicotinamide Mononucleotide (CAS 1094-61-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

ß-Nicotinamide Mononucleotide (CAS 1094-61-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 51 Pages
  • Global
From
Nicotinamide Adenine Dinucleotide Market Report 2026 - Product Image

Nicotinamide Adenine Dinucleotide Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Nicotinamide Adenine Dinucleotide Products Market Forecast to 2033 - Product Image

Nicotinamide Adenine Dinucleotide Products Market Forecast to 2033

  • Report
  • 109 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.